Indications
Klisyri is indicated for the field treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis (Olsen grade 1) of the face or scalp in adults.
Composition
- Active substance
- tirbanibulin
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Klisyri
- Active substance
- tirbanibulin
- ATC code
- D06BX03
- Group
- Dermatologicals
- Therapeutic area
- Keratosis, Actinic
- Marketing authorisation holder
- Almirall, S.A.
- Status
- Authorised
- EU authorisation
- 16 Jul 2021
- EMA product number